Skip to main content
. 2021 Sep 20;12:742631. doi: 10.3389/fimmu.2021.742631

Figure 2.

Figure 2

Levels of IgGs against prevalent herpesviruses in plasma from patients with different presentations of COVID-19. Levels of IgGs against CMV (A), HSV-1 (B), EBV (C) and VZV (D) in plasma from patients with mild, severe and critical forms of COVID-19. Data shown are mean ± SEM. Each dot represents data from one individual. Statistical significance was calculated using one-way ANOVA and Tukey’s multiple comparisons test. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.